Prediction of Parp Inhibitor Response and Resistance Utilizing A Ctc Phenotypic Classifer in Patients (pts) with Metastatic Castration-Resistant Prostate Cancer (mcrpc): Results from the Nci 9012 Trial
ANNALS OF ONCOLOGY(2016)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要